| P50 | author | Rongbin Yu | Q89209821 |
| | Zhihang Peng | Q93235677 |
| P2093 | author name string | Lu Wang | |
| | Hui Zheng | |
| | Peng Huang | |
| | Qing Wang | |
| | Wei Guo | |
| | Ning Wang | |
| | Jessie Norris | |
| P2860 | cites work | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 |
| | Missed opportunities for HIV testing and late-stage diagnosis among HIV-infected patients in Uganda | Q28478923 |
| | Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 |
| | HIV-infected former plasma donors in rural Central China: from infection to survival outcomes, 1985-2008. | Q33742029 |
| | Natural history of HIV infection in the era of combination antiretroviral therapy | Q33876280 |
| | Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis | Q33939861 |
| | Decline in the AIDS and death rates in the EuroSIDA study: an observational study | Q33967061 |
| | Determinants of survival following HIV-1 seroconversion after the introduction of HAART. | Q33973379 |
| | Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. | Q34067875 |
| | Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. | Q34068078 |
| | Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies | Q34139859 |
| | Five-year outcomes of the China National Free Antiretroviral Treatment Program | Q34997946 |
| | Causes of the decline in AIDS deaths, United States, 1995-2002: prevention, treatment or both? | Q36335487 |
| | Scaling up antiretroviral therapy in South Africa: the impact of speed on survival | Q36711798 |
| | The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in China. | Q36882323 |
| | HIV and syphilis prevalence among men who have sex with men: a cross-sectional survey of 61 cities in China. | Q36946251 |
| | Declining AIDS mortality in Amsterdam: contributions of declining HIV incidence and effective therapy | Q38477705 |
| | Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease | Q38492858 |
| | Death caused by drug addiction: a review of the experiences in Hamburg and the situation in the Federal Republic of Germany in comparison with the literature | Q38757244 |
| | Levels and causes of adult mortality in rural South Africa: the impact of AIDS. | Q39077610 |
| | Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control | Q39163402 |
| | Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. | Q40433154 |
| | Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire. | Q43761484 |
| | Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study | Q43925184 |
| | Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients | Q44097497 |
| | Rapidly increasing prevalence of HIV and syphilis and HIV-1 subtype characterization among men who have sex with men in Jiangsu, China | Q44947293 |
| | Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy | Q46624490 |
| | Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme | Q46749447 |
| | Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study | Q46863163 |
| | Recent trends in HIV-related inpatient admissions 1996-2000: a 7-state study | Q47614760 |
| | Clinical outcomes and immune reconstitution in 103 advanced AIDS patients undergoing 12-month highly active antiretroviral therapy. | Q51977744 |
| | Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. | Q53608173 |
| | All cause mortality in the Swiss HIV cohort study from 1990 to 2001 in comparison with the Swiss population | Q57794046 |
| | Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study | Q57877938 |
| | Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy | Q77230682 |
| | Antiretroviral therapy in AIDS patients with CMV disease: impact on the survival and long-term treatment outcome | Q94608282 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 831 | |
| P577 | publication date | 2014-08-11 | |
| P1433 | published in | BMC Public Health | Q15767009 |
| P1476 | title | Incidence and risk factors for AIDS-related mortality in HIV patients in China: a cross-sectional study | |
| P478 | volume | 14 | |